Literature DB >> 33377664

Clinical efficacy of convalescent plasma therapy on treating COVID-19 patients: Evidence from matched study and a meta-analysis.

Weijun Jiang1, Weiwei Li1, Lei Xiong1, Qiuyue Wu1, Jian Wu1, Bangshun He1,2, Jiawei Shen1, Rongrong Pang1,3, Tao Luo1, Yanju Guo1, Yang Yang1, Ying Han1, Wei Dai1, Peiran Zhu1, Xinyi Xia1,4,5.   

Abstract

Entities:  

Year:  2020        PMID: 33377664      PMCID: PMC7752155          DOI: 10.1002/ctm2.259

Source DB:  PubMed          Journal:  Clin Transl Med        ISSN: 2001-1326


× No keyword cloud information.
  8 in total

1.  Effect of Convalescent Plasma Therapy on Time to Clinical Improvement in Patients With Severe and Life-threatening COVID-19: A Randomized Clinical Trial.

Authors:  Ling Li; Wei Zhang; Yu Hu; Xunliang Tong; Shangen Zheng; Juntao Yang; Yujie Kong; Lili Ren; Qing Wei; Heng Mei; Caiying Hu; Cuihua Tao; Ru Yang; Jue Wang; Yongpei Yu; Yong Guo; Xiaoxiong Wu; Zhihua Xu; Li Zeng; Nian Xiong; Lifeng Chen; Juan Wang; Ning Man; Yu Liu; Haixia Xu; E Deng; Xuejun Zhang; Chenyue Li; Conghui Wang; Shisheng Su; Linqi Zhang; Jianwei Wang; Yanyun Wu; Zhong Liu
Journal:  JAMA       Date:  2020-08-04       Impact factor: 56.272

2.  Clinical Characteristics of Coronavirus Disease 2019 in China.

Authors:  Wei-Jie Guan; Zheng-Yi Ni; Yu Hu; Wen-Hua Liang; Chun-Quan Ou; Jian-Xing He; Lei Liu; Hong Shan; Chun-Liang Lei; David S C Hui; Bin Du; Lan-Juan Li; Guang Zeng; Kwok-Yung Yuen; Ru-Chong Chen; Chun-Li Tang; Tao Wang; Ping-Yan Chen; Jie Xiang; Shi-Yue Li; Jin-Lin Wang; Zi-Jing Liang; Yi-Xiang Peng; Li Wei; Yong Liu; Ya-Hua Hu; Peng Peng; Jian-Ming Wang; Ji-Yang Liu; Zhong Chen; Gang Li; Zhi-Jian Zheng; Shao-Qin Qiu; Jie Luo; Chang-Jiang Ye; Shao-Yong Zhu; Nan-Shan Zhong
Journal:  N Engl J Med       Date:  2020-02-28       Impact factor: 91.245

3.  Mortality reduction in 46 severe Covid-19 patients treated with hyperimmune plasma. A proof of concept single arm multicenter trial.

Authors:  Cesare Perotti; Fausto Baldanti; Raffaele Bruno; Claudia Del Fante; Elena Seminari; Salvatore Casari; Elena Percivalle; Claudia Glingani; Valeria Musella; Mirko Belliato; Martina Garuti; Federica Meloni; Marilena Frigato; Antonio Di Sabatino; Catherine Klersy; Giuseppe De Donno; Massimo Franchini
Journal:  Haematologica       Date:  2020-12-01       Impact factor: 9.941

Review 4.  The effectiveness of convalescent plasma and hyperimmune immunoglobulin for the treatment of severe acute respiratory infections of viral etiology: a systematic review and exploratory meta-analysis.

Authors:  John Mair-Jenkins; Maria Saavedra-Campos; J Kenneth Baillie; Paul Cleary; Fu-Meng Khaw; Wei Shen Lim; Sophia Makki; Kevin D Rooney; Jonathan S Nguyen-Van-Tam; Charles R Beck
Journal:  J Infect Dis       Date:  2014-07-16       Impact factor: 5.226

5.  Clinical efficacy of convalescent plasma for treatment of COVID-19 infections: Results of a multicenter clinical study.

Authors:  Hassan Abolghasemi; Peyman Eshghi; Abdol Majid Cheraghali; Abbas Ali Imani Fooladi; Farzaneh Bolouki Moghaddam; Sina Imanizadeh; Matin Moeini Maleki; Mohammad Ranjkesh; Mohammad Rezapour; Ali Bahramifar; Behzad Einollahi; Mohammad Javad Hosseini; Nematollah Joneidi Jafari; Mohamad Nikpouraghdam; Nariman Sadri; Mokhtar Tazik; Shanaz Sali; Shamsi Okati; Elham Askari; Payam Tabarsi; Jafar Aslani; Ehsan Sharifipour; Mohammad Hossein Jarahzadeh; Nastaran Khodakarim; Mahmood Salesi; Ramezan Jafari; Samira Shahverdi
Journal:  Transfus Apher Sci       Date:  2020-07-15       Impact factor: 1.764

6.  Use of convalescent plasma in hospitalized patients with COVID-19: case series.

Authors:  Livia Hegerova; Ted A Gooley; Kelly A Sweerus; Cynthia Maree; Neil Bailey; Megumi Bailey; Vanessa Dunleavy; Krish Patel; Kirsten Alcorn; Rebecca Haley; Jill M Johnsen; Barbara A Konkle; Annamarie C Lahti; Morgan L Alexander; Jason D Goldman; Anne Lipke; Sun-Jung Lim; Mark D Sullivan; John S Pauk; John M Pagel
Journal:  Blood       Date:  2020-08-06       Impact factor: 25.476

  8 in total
  8 in total

1.  Convalescent plasma associates with reduced mortality and improved clinical trajectory in patients hospitalized with COVID-19.

Authors:  Shanna A Arnold Egloff; Angela Junglen; Joseph Sa Restivo; Marjorie Wongskhaluang; Casey Martin; Pratik Doshi; Daniel Schlauch; Gregg Fromell; Lindsay E Sears; Mick Correll; Howard A Burris; Charles F LeMaistre
Journal:  J Clin Invest       Date:  2021-10-15       Impact factor: 14.808

Review 2.  Efficacy and secondary infection risk of tocilizumab, sarilumab and anakinra in COVID-19 patients: A systematic review and meta-analysis.

Authors:  Jingwen Peng; Meihua Fu; Huan Mei; Hailin Zheng; Guanzhao Liang; Xiaodong She; Qiong Wang; Weida Liu
Journal:  Rev Med Virol       Date:  2021-09-24       Impact factor: 11.043

Review 3.  Sex Differences in Glioblastoma Immunotherapy Response.

Authors:  Juyeun Lee; Kristen Kay; Katie Troike; Manmeet S Ahluwalia; Justin D Lathia
Journal:  Neuromolecular Med       Date:  2021-04-17       Impact factor: 3.843

4.  COVID-19 convalescent plasma therapy: hit fast, hit hard!

Authors:  Daniele Focosi; Massimo Franchini
Journal:  Vox Sang       Date:  2021-04-01       Impact factor: 2.996

5.  How to translate the knowledge of COVID-19 into the prevention of Omicron variants.

Authors:  Xiangdong Wang; Charles A Powell
Journal:  Clin Transl Med       Date:  2021-12

6.  Association between tocilizumab treatment and clinical outcomes of COVID-19 patients: a systematic review and meta-analysis.

Authors:  Jingwen Peng; Xiaodong She; Huan Mei; Hailin Zheng; Meihua Fu; Guanzhao Liang; Qiong Wang; Weida Liu
Journal:  Aging (Albany NY)       Date:  2022-01-17       Impact factor: 5.682

Review 7.  COVID-19 Convalescent Plasma and Clinical Trials: Understanding Conflicting Outcomes.

Authors:  Daniele Focosi; Massimo Franchini; Liise-Anne Pirofski; Thierry Burnouf; Nigel Paneth; Michael J Joyner; Arturo Casadevall
Journal:  Clin Microbiol Rev       Date:  2022-03-09       Impact factor: 50.129

8.  Efficacy and Safety of Tocilizumab Treatment COVID-19 Patients: A Case-Control Study and Meta-Analysis.

Authors:  Weijun Jiang; Weiwei Li; Qiuyue Wu; Ying Han; Jing Zhang; Tao Luo; Yanju Guo; Yang Yang; Peiran Zhu; Xinyi Xia
Journal:  Infect Dis Ther       Date:  2021-07-09
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.